Familial hypocalciuric hypercalcemia is said to be an extremely rare condition but is clinically important because it can be confused with primary hyperparathyroidism. The biochemical features of the two conditions are similar, but the former is benign while the latter can have serious clinical consequences with patients occasionally proceeding to parathyroidectomy. It is therefore important to differentiate accurately between the two. With this in mind it would be useful to know the prevalence of familial hypocalciuric hypercalcemia when considering the differential diagnosis of primary hyperparathyroidism. However, as far as we are aware, no estimate of the prevalence of this condition can be found in the literature. We describe how an estimate was made of the prevalence of familial hypocalciuric hypercalcemia in the west of Scotland. We estimate the prevalence to be 1 in 78,000 at least.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.